Literature DB >> 31094425

Interpretation of the Individual Effect Under Treatment Spillover.

Forrest W Crawford1,2,3, Olga Morozova1, Ashley L Buchanan4, Donna Spiegelman1,5,6.   

Abstract

Some interventions are intended to benefit both individuals and the groups to which they belong. When a treatment given to one person exerts a causal effect on others, the treatment is said to exhibit spillover, dissemination, or interference. However, defining meaningful causal effects under spillover can be challenging. In this commentary, we discuss the meaning of the "individual effect," a quantity proposed to summarize the effect of treatment on the person who receives it, when spillover may be present.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Keywords:  causal inference; dissemination; injection drug use; interference; randomization; spillover

Year:  2019        PMID: 31094425      PMCID: PMC6686621          DOI: 10.1093/aje/kwz108

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  13 in total

1.  Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis.

Authors:  Deborah Donnell; Jared M Baeten; James Kiarie; Katherine K Thomas; Wendy Stevens; Craig R Cohen; James McIntyre; Jairam R Lingappa; Connie Celum
Journal:  Lancet       Date:  2010-05-26       Impact factor: 79.321

2.  Toward Causal Inference With Interference.

Authors:  Michael G Hudgens; M Elizabeth Halloran
Journal:  J Am Stat Assoc       Date:  2008-06       Impact factor: 5.033

3.  Effect partitioning under interference in two-stage randomized vaccine trials.

Authors:  Tyler J Vanderweele; Eric J Tchetgen Tchetgen
Journal:  Stat Probab Lett       Date:  2011-07-01       Impact factor: 0.870

4.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

5.  Assessing Individual and Disseminated Effects in Network-Randomized Studies.

Authors:  Ashley L Buchanan; Sten H Vermund; Samuel R Friedman; Donna Spiegelman
Journal:  Am J Epidemiol       Date:  2018-11-01       Impact factor: 4.897

6.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.

Authors:  Michael C Thigpen; Poloko M Kebaabetswe; Lynn A Paxton; Dawn K Smith; Charles E Rose; Tebogo M Segolodi; Faith L Henderson; Sonal R Pathak; Fatma A Soud; Kata L Chillag; Rodreck Mutanhaurwa; Lovemore Ian Chirwa; Michael Kasonde; Daniel Abebe; Evans Buliva; Roman J Gvetadze; Sandra Johnson; Thom Sukalac; Vasavi T Thomas; Clyde Hart; Jeffrey A Johnson; C Kevin Malotte; Craig W Hendrix; John T Brooks
Journal:  N Engl J Med       Date:  2012-07-11       Impact factor: 91.245

7.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

Authors:  Jens D Lundgren; Abdel G Babiker; Fred Gordin; Sean Emery; Birgit Grund; Shweta Sharma; Anchalee Avihingsanon; David A Cooper; Gerd Fätkenheuer; Josep M Llibre; Jean-Michel Molina; Paula Munderi; Mauro Schechter; Robin Wood; Karin L Klingman; Simon Collins; H Clifford Lane; Andrew N Phillips; James D Neaton
Journal:  N Engl J Med       Date:  2015-07-20       Impact factor: 91.245

8.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.

Authors:  Kachit Choopanya; Michael Martin; Pravan Suntharasamai; Udomsak Sangkum; Philip A Mock; Manoj Leethochawalit; Sithisat Chiamwongpaet; Praphan Kitisin; Pitinan Natrujirote; Somyot Kittimunkong; Rutt Chuachoowong; Roman J Gvetadze; Janet M McNicholl; Lynn A Paxton; Marcel E Curlin; Craig W Hendrix; Suphak Vanichseni
Journal:  Lancet       Date:  2013-06-13       Impact factor: 79.321

9.  Two cases of intranasal naloxone self-administration in opioid overdose.

Authors:  Traci C Green; Madeline Ray; Sarah E Bowman; Michelle McKenzie; Josiah D Rich
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

10.  Spillover effects in epidemiology: parameters, study designs and methodological considerations.

Authors:  Jade Benjamin-Chung; Benjamin F Arnold; David Berger; Stephen P Luby; Edward Miguel; John M Colford; Alan E Hubbard
Journal:  Int J Epidemiol       Date:  2018-02-01       Impact factor: 7.196

View more
  2 in total

1.  Emulating Target Trials to Improve Causal Inference From Agent-Based Models.

Authors:  Eleanor J Murray; Brandon D L Marshall; Ashley L Buchanan
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

Review 2.  Discrepancies in Control Group Mortality Rates Within Studies Assessing Topical Antibiotic Strategies to Prevent Ventilator-Associated Pneumonia: An Umbrella Review.

Authors:  James C Hurley
Journal:  Crit Care Explor       Date:  2020-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.